Gene Editing Off-Target Effect Detection Test Systems Market

Gene editing off-target effect detection test systems sales will expand through 2036, with CRISPR-cas9 at 42.3% of the editing modality category in 2026. The market was valued at USD 391.8 million in 2025, is projected to reach USD 1,555.1 million by 2036 and is forecast to record a 13.4% CAGR between 2026 and 2036.